Dr Amy Walker

COO & EVP of Research and Business Development at 4Basebio

Speaker

Dr Amy Walker has 10+ years scientific and commercial experience in life sciences, and currently serves as COO of 4basebio, an innovative platform technology company focussed on the production of synthetic DNA products for gene therapy and vaccine development. Here, Amy is responsible for the company’s synthetic DNA and targeted non-viral delivery platforms and their commercial development. She received her PhD from the Institute of Child Health, University College London. During her academic career, Dr Walker explored the use of nanoparticles for delivery of CRISPR/Cas9 for treatment of Cystic Fibrosis. Amy authored numerous peer reviewed papers and is named inventor on a multitude of patents spanning wide ranging disciplines. She currently serves as non-executive director at Neomatrix and Heqet Tx.